Predictive Tools for Older Cancer Patient Management

2019 ◽  
pp. 1-15
Author(s):  
Ki Hyang Kim ◽  
Martine Extermann
Keyword(s):  
Cancer Patient ◽  
Patient Management ◽  
Predictive Tools

scholarly journals Saving costs in cancer patient management through molecular imaging

2017 ◽  
Vol 44 (13) ◽  
pp. 2153-2157
Author(s):  
Carl von Gall ◽  
Piotr Maniawski ◽  
Fred Verzijlbergen ◽  
Ignasi Carrio ◽  
Thomas Beyer ◽  
...  
Keyword(s):  
Molecular Imaging ◽  
Cancer Patient ◽  
Patient Management

Abstract PR05: Investigating the importance of low allele frequency mutations for cancer patient management

2015 ◽  
Author(s):  
Ken Chen ◽  
Funda Meric-Bernstam ◽  
Hao Zhao ◽  
Tenghui Chen ◽  
Kenna Shaw ◽  
...  
Keyword(s):  
Cancer Patient ◽  
Allele Frequency ◽  
Patient Management

A PET imaging approach for determining EGFR mutation status for improved lung cancer patient management

2018 ◽  
Vol 10 (431) ◽  
pp. eaan8840 ◽  
Author(s):  
Xilin Sun ◽  
Zunyu Xiao ◽  
Gongyan Chen ◽  
Zhaoguo Han ◽  
Yang Liu ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cancer Patient ◽  
Pet Imaging ◽  
Patient Management ◽  
Lung Cancer Patient ◽  
Egfr Mutation ◽  
Mutation Status ◽  
Imaging Approach

scholarly journals EMT-Associated Heterogeneity in Circulating Tumor Cells: Sticky Friends on the Road to Metastasis

Cancers ◽  
2020 ◽  
Vol 12 (6) ◽  
pp. 1632 ◽  
Author(s):  
Anthony Genna ◽  
Aline M. Vanwynsberghe ◽  
Amélie V. Villard ◽  
Charles Pottier ◽  
Julien Ancel ◽  
...  
Keyword(s):  
Personalized Medicine ◽  
Cancer Patient ◽  
Tumor Cells ◽  
Circulating Tumor Cells ◽  
Crucial Role ◽  
Patient Management ◽  
The Road ◽  
Metastatic Colonization ◽  
On The Road ◽  
Early Phases

Epithelial–mesenchymal transitions (EMTs) generate hybrid phenotypes with an enhanced ability to adapt to diverse microenvironments encountered during the metastatic spread. Accordingly, EMTs play a crucial role in the biology of circulating tumor cells (CTCs) and contribute to their heterogeneity. Here, we review major EMT-driven properties that may help hybrid Epithelial/Mesenchymal CTCs to survive in the bloodstream and accomplish early phases of metastatic colonization. We then discuss how interrogating EMT in CTCs as a companion biomarker could help refine cancer patient management, further supporting the relevance of CTCs in personalized medicine.

Sign in / Sign up

Export Citation Format

Share Document